REGENEREX PHARMA, INC. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Regenerex Pharma, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Regenerex Pharma, Inc. Return On Equity for the quarter ending December 31, 2024 was 31 %, a 77.2% decline year-over-year.
  • Regenerex Pharma, Inc. annual Return On Equity for 2023 was 335 %, a 2151% increase from 2022.
  • Regenerex Pharma, Inc. annual Return On Equity for 2022 was 14.9 %, a 54.5% decline from 2021.
  • Regenerex Pharma, Inc. annual Return On Equity for 2021 was 32.7 %, a 59.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 335 +320 +2151% Apr 1, 2023 Mar 31, 2024
2022 14.9 -17.8 -54.5% Apr 1, 2022 Mar 31, 2023
2021 32.7 -48.4 -59.7% Apr 1, 2021 Mar 31, 2022
2020 81.1 +113 Apr 1, 2020 Mar 31, 2021
2019 -31.7 -61.8 -205% Apr 1, 2019 Mar 31, 2020
2018 30.1 Apr 1, 2018 Mar 31, 2019
2014 -84 Dec 1, 2013 Nov 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.